Interleukin-4 suppresses plasminogen activator inhibitor-2 formation in stimulated human monocytes

J. A. Hamilton, G. A. Whitty, K. Last, A. K. Royston, P. H. Hart, D. R. Burgess

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)


Using a specific enzyme-linked immunosorbent assay, plasminogen activator inhibitor-2 (PAI-2) was quantitated in cultures of human monocytes. Lipopolysaccharide (LPS) increased both extracellular and cell-associated PAI-2 levels, as well as PAI-2 mRNA measured by Northern analysis. Both the lymphokine, interleukin-4 (IL-4) (≥10 pmol/L), and the glucocorticoid, dexamethasone (100 nmol/L), inhibited PAI-2 formation and PAI-2 mRNA induction. Another lymphokine, interferon-γ (IFN-γ) (100 U/mL), as for IL-4 alone, did not stimulate PAI-2 formation; however, in contrast to IL-4, IFN- γ did not reverse the LPS effect but could potentiate it. The suppression of PAI-2 formation by IL-4 and glucocorticoid in stimulated human monocytes extends the list of monocyte products whose synthesis can be downregulated in these cells by the two agents. The findings could have relevance to the control by monocytes/macrophages of connective tissue resorption, including that of fibrin, at sites of inflammation.

Original languageEnglish
Pages (from-to)121-125
Number of pages5
Issue number1
Publication statusPublished - 1 Jan 1992
Externally publishedYes


Dive into the research topics of 'Interleukin-4 suppresses plasminogen activator inhibitor-2 formation in stimulated human monocytes'. Together they form a unique fingerprint.

Cite this